By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Cambridge Organoid Technology Offers New Path to Reversing Spinal Cord Injuries

Cambridge Organoid Technology Offers New Path to Reversing Spinal Cord Injuries

GMJ
Last updated: 05/06/2026 16:52
By
GMJ News Desk
Share
1 Min Read
Microscopic view of lab-grown brain organoids showing neural connections and regenerating nerve fibers
Cambridge researchers used lab-grown brain organoids to discover that human neurons lose regenerative capacity during development, but thyroid hormone therapy can restore nerve regrowth by 10-fold. The breakthrough offers new hope for treating paralysis and spinal cord injuries. — Photo: Google DeepMind / Pexels
SHARE
1 min read|147 words

Researchers at Cambridge University have achieved a significant advancement in neural regeneration using laboratory-grown brain and spinal cord organoids. The breakthrough demonstrates that nerve damage previously considered irreversible may be treatable through targeted hormone therapy. Using three-dimensional tissue models grown from human stem cells, the Cambridge team successfully created functional neural circuits capable of transmitting electrical signals and triggering muscle contractions. The research reveals that human neurons progressively lose their regenerative capacity during development, transitioning from near-complete regeneration in embryonic stages to minimal regrowth in adult neurons. However, the study shows this decline is not permanent. When treated with thyroid hormone therapy, adult neurons in the organoid models demonstrated a remarkable 10-fold increase in nerve fiber regrowth. Dr. Stefano Patani and his team believe these findings could unlock new therapeutic strategies for treating paralysis, spinal cord injuries, and neurodegenerative diseases. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Lab-grown brain organoids reveal how to reverse ‘irreversible’ nerve damage →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
PCOS Name Change Campaign Gains Momentum as Women Seek Better Understanding

More than 170 million women worldwide live with PCOS, yet growing advocacy…

Women’s Empowerment Programs in Poor Countries Lack Clear Measurement Standards

A comprehensive scoping review reveals significant gaps in how women's empowerment programs…

Brown Dog Tick Linked to Fatal SFTS Case with Multiorgan Failure in Thailand

Thai researchers document first confirmed case of SFTS virus transmission by brown…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Announcement: UN Aviation Agency Urges Airlines to Maintain COVID-Era Safety Protocols Amid DRC Ebola Outbreak

By
GMJ News Desk
03/06/2026

WHO Declares Public Health Emergency Over Ebola Outbreak With Cross-Border Spread

By
GMJ News Desk
31/05/2026
Clinical UpdatesNew StudiesPracticeResearch Digest

Phase 1 trials reveal safety profile of rimteravimab antibody for COVID-19 treatment

By
GMJ News Desk
03/06/2026
Map showing Ebola outbreak locations in Democratic Republic of Congo and Uganda with WHO emergency response indicators

WHO Escalates Response as Ebola Crosses DRC-Uganda Border

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up